181 related articles for article (PubMed ID: 38001578)
1. Dpep Inhibits Cancer Cell Growth and Survival via Shared and Context-Dependent Transcriptome Perturbations.
Zhou Q; Greene LA
Cancers (Basel); 2023 Nov; 15(22):. PubMed ID: 38001578
[TBL] [Abstract][Full Text] [Related]
2. Cell-Penetrating CEBPB and CEBPD Leucine Zipper Decoys as Broadly Acting Anti-Cancer Agents.
Zhou Q; Sun X; Pasquier N; Jefferson P; Nguyen TTT; Siegelin MD; Angelastro JM; Greene LA
Cancers (Basel); 2021 May; 13(10):. PubMed ID: 34065488
[TBL] [Abstract][Full Text] [Related]
3. Dominant-Negative ATF5 Compromises Cancer Cell Survival by Targeting CEBPB and CEBPD.
Sun X; Jefferson P; Zhou Q; Angelastro JM; Greene LA
Mol Cancer Res; 2020 Feb; 18(2):216-228. PubMed ID: 31676720
[TBL] [Abstract][Full Text] [Related]
4. Targeting Transcription Factors ATF5, CEBPB and CEBPD with Cell-Penetrating Peptides to Treat Brain and Other Cancers.
Greene LA; Zhou Q; Siegelin MD; Angelastro JM
Cells; 2023 Feb; 12(4):. PubMed ID: 36831248
[TBL] [Abstract][Full Text] [Related]
5. A PDX1-ATF transcriptional complex governs β cell survival during stress.
Juliana CA; Yang J; Cannon CE; Good AL; Haemmerle MW; Stoffers DA
Mol Metab; 2018 Nov; 17():39-48. PubMed ID: 30174228
[TBL] [Abstract][Full Text] [Related]
6. Microarray gene expression profiling in colorectal (HCT116) and hepatocellular (HepG2) carcinoma cell lines treated with
Kabir MF; Mohd Ali J; Haji Hashim O
PeerJ; 2018; 6():e5203. PubMed ID: 30042885
[TBL] [Abstract][Full Text] [Related]
7. A Synthetic Cell-Penetrating Dominant-Negative ATF5 Peptide Exerts Anticancer Activity against a Broad Spectrum of Treatment-Resistant Cancers.
Karpel-Massler G; Horst BA; Shu C; Chau L; Tsujiuchi T; Bruce JN; Canoll P; Greene LA; Angelastro JM; Siegelin MD
Clin Cancer Res; 2016 Sep; 22(18):4698-711. PubMed ID: 27126996
[TBL] [Abstract][Full Text] [Related]
8. CHOP induces activating transcription factor 5 (ATF5) to trigger apoptosis in response to perturbations in protein homeostasis.
Teske BF; Fusakio ME; Zhou D; Shan J; McClintick JN; Kilberg MS; Wek RC
Mol Biol Cell; 2013 Aug; 24(15):2477-90. PubMed ID: 23761072
[TBL] [Abstract][Full Text] [Related]
9. Trans-1,3-diphenyl-2,3-epoxypropan-1-one, a chalcone derivative, induces apoptosis via ROS-mediated down-regulation of Bcl-xL in human leukemia HL-60 cells.
Ko EY; Lee SH; Ko JY; Moon JY; Yoon WJ; Ahn G; Roh SW; Cho K; Jeon YJ; Kim D; Kim KN
EXCLI J; 2015; 14():900-7. PubMed ID: 27103891
[TBL] [Abstract][Full Text] [Related]
10. Integrated transcriptome and in vitro analysis revealed anti-proliferative effect of citral in human stomach cancer through apoptosis.
Balusamy SR; Ramani S; Natarajan S; Kim YJ; Perumalsamy H
Sci Rep; 2019 Mar; 9(1):4883. PubMed ID: 30890753
[TBL] [Abstract][Full Text] [Related]
11. Exposure to dipentyl phthalate in utero disrupts the adrenal cortex function of adult male rats by inhibiting SIRT1/PGC-1α and inducing AMPK phosphorylation.
Chen H; Liu M; Li Q; Zhou P; Huang J; Zhu Q; Li Z; Ge RS
Environ Toxicol; 2023 May; 38(5):997-1010. PubMed ID: 36715143
[TBL] [Abstract][Full Text] [Related]
12. Dissecting super-enhancer driven transcriptional dependencies reveals novel therapeutic strategies and targets for group 3 subtype medulloblastoma.
Li M; Han Y; Wang C; Kang W; Jiang W; Zhang L; Tang Y
J Exp Clin Cancer Res; 2022 Oct; 41(1):311. PubMed ID: 36273157
[TBL] [Abstract][Full Text] [Related]
13. Death associated proteins (DAPs): from gene identification to the analysis of their apoptotic and tumor suppressive functions.
Levy-Strumpf N; Kimchi A
Oncogene; 1998 Dec; 17(25):3331-40. PubMed ID: 9916995
[TBL] [Abstract][Full Text] [Related]
14. In vitro downregulated hypoxia transcriptome is associated with poor prognosis in breast cancer.
Abu-Jamous B; Buffa FM; Harris AL; Nandi AK
Mol Cancer; 2017 Jun; 16(1):105. PubMed ID: 28619028
[TBL] [Abstract][Full Text] [Related]
15. Induction of pro-apoptotic and cell cycle-inhibiting genes in chromium (VI)-treated human lung fibroblasts: lack of effect of ERK.
Ceryak S; Zingariello C; O'Brien T; Patierno SR
Mol Cell Biochem; 2004 Jan; 255(1-2):139-49. PubMed ID: 14971655
[TBL] [Abstract][Full Text] [Related]
16. The transcription factor ATF5: role in cellular differentiation, stress responses, and cancer.
Sears TK; Angelastro JM
Oncotarget; 2017 Oct; 8(48):84595-84609. PubMed ID: 29137451
[TBL] [Abstract][Full Text] [Related]
17. Identification of differentially expressed genes in nasopharyngeal carcinoma by means of the Atlas human cancer cDNA expression array.
Xie L; Xu L; He Z; Zhou W; Wang L; Zhang L; Lan K; Ren C; Liu W; Yao K
J Cancer Res Clin Oncol; 2000 Jul; 126(7):400-6. PubMed ID: 10929762
[TBL] [Abstract][Full Text] [Related]
18. Human Cytomegalovirus Infection Activates Glioma Activating Transcription Factor 5 via microRNA in a Stress-Induced Manner.
Hu M; Yu B; Zhang B; Wang B; Qian D; Li H; Ma J; Liu DX
ACS Chem Neurosci; 2021 Oct; 12(20):3947-3956. PubMed ID: 34617722
[TBL] [Abstract][Full Text] [Related]
19. CEBPD is a master transcriptional factor for hypoxia regulated proteins in glioblastoma and augments hypoxia induced invasion through extracellular matrix-integrin mediated EGFR/PI3K pathway.
Mao XG; Xue XY; Lv R; Ji A; Shi TY; Chen XY; Jiang XF; Zhang X
Cell Death Dis; 2023 Apr; 14(4):269. PubMed ID: 37059730
[TBL] [Abstract][Full Text] [Related]
20. Targeting Super-Enhancer-Associated Oncogenes in Osteosarcoma with THZ2, a Covalent CDK7 Inhibitor.
Zhang J; Liu W; Zou C; Zhao Z; Lai Y; Shi Z; Xie X; Huang G; Wang Y; Zhang X; Fan Z; Su Q; Yin J; Shen J
Clin Cancer Res; 2020 Jun; 26(11):2681-2692. PubMed ID: 31937612
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
